0
0

ORPHAN Cures Act

12/19/2024, 9:06 AM

Summary of Bill HR 5539

The Bill 118 hr 5539, also known as the ORPHAN Cures Act, is a piece of legislation introduced in the US Congress with the aim of addressing the needs of individuals with rare diseases, also known as orphan diseases. The bill seeks to improve access to treatments and cures for these diseases by providing funding for research and development of orphan drugs.

Specifically, the ORPHAN Cures Act aims to streamline the drug approval process for orphan drugs, which are medications designed to treat rare diseases that affect a small number of individuals. The bill also seeks to incentivize pharmaceutical companies to develop orphan drugs by providing tax credits and other financial incentives.

Additionally, the ORPHAN Cures Act includes provisions to improve coordination between government agencies, healthcare providers, and patient advocacy groups in order to better support individuals with rare diseases. The bill also calls for increased funding for research into orphan diseases and for the establishment of a national registry to track the prevalence of these conditions. Overall, the ORPHAN Cures Act is a comprehensive piece of legislation aimed at improving access to treatments and cures for individuals with rare diseases. It seeks to address the unique challenges faced by individuals with orphan diseases and to promote innovation in the development of new therapies.

Read the Full Bill

Formatted TextPDFFormatted XML

Current Status of Bill HR 5539

Bill HR 5539 is currently in the status of Bill Introduced since September 18, 2023. Bill HR 5539 was introduced during Congress 118 and was introduced to the House on September 18, 2023.  Bill HR 5539's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 5539

Total Number of Sponsors
2
Democrat Sponsors
0
Republican Sponsors
2
Unaffiliated Sponsors
0
Total Number of Cosponsors
8
Democrat Cosponsors
4
Republican Cosponsors
4
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 5539

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 5539

ORPHAN Cures Act
ORPHAN Cures Act
Optimizing Research Progress Hope And New Cures Act
To amend title XI of the Social Security Act to expand and clarify the exclusion for orphan drugs under the Drug Price Negotiation Program.

Comments

Sponsors and Cosponsors of HR 5539

John Joyce
John Joyce
PennsylvaniaRepublican
Lloyd Smucker
Lloyd Smucker
PennsylvaniaRepublican
Scott H. Peters
Scott H. Peters
CaliforniaDemocrat
Wiley Nickel
Wiley Nickel
North CarolinaDemocrat
Mariannette Miller-Meeks
Mariannette Miller-Meeks
IowaRepublican
Kevin Hern
Kevin Hern
OklahomaRepublican

Latest Bills

A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-07: Reasonable Investigation of Consumer Reporting Disputes".
Bill SJRES 173April 14, 2026
A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress.
Bill SJRES 172April 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Disclosure of Consumer Complaint Narrative Data".
Bill SJRES 176April 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Procedures for Supervisory Designation Proceedings".
Bill SJRES 178April 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Bulletin 2015-02 re: Section 8 housing choice voucher homeownership program".
Bill SJRES 165April 14, 2026
A bill to provide for export restrictions on certain semiconductor manufacturing equipment and components therefor, and for other purposes.
Bill S 4281April 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Compliance Bulletin 2016-03: Detecting and Preventing Consumer Harm From Production Incentives".
Bill SJRES 170April 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Education relating to "William D. Ford Federal Direct Loan (Direct Loan) Program".
Bill SJRES 182April 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Information Requests to Large Banks and Credit Unions".
Bill SJRES 167April 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Equal Credit Opportunity (Regulation B); Discrimination on the Bases of Sexual Orientation and Gender Identity".
Bill SJRES 166April 14, 2026
ORPHAN Cures Act
Bill S 3131December 15, 2023